Mégane Noirfalise
Meet our Life Sciences team at CRISP San Francisco and don't miss our presentation
On February 24th 2022, our N-SIDE Life Sciences experts will be at California Regional Investigational Supplies Professionals (CRISP) - San Francisco. Don't hesitate to meet them at our booth to talk and learn all you need to know about end-to-end clinical supply chain optimization and our optimization software, the N-SIDE Suite!
- WHEN? February 24 | Starting time: From 09:00AM PST
- WHERE? Marriott San Francisco Airport Waterfront, Burlingame California
Want to know more about what we do? Don't miss N-SIDE’s Life Sciences Senior Consultants, Antoine Remiot and Maxime Derep, presenting during the plenary session. The will talk about:
"Moving away from Excel forecasts with risk-based optimization"
Join us to learn more about:
- Which misused assumptions can cost you an extra 20% IMP waste;
- the impact each input (cohorts, titrations, dropout, weight/BSA distribution, and more) has on supply chain forecasts and patient risk;
- and discover a case study showing how to move from Excel forecasts to a risk-free and minimized drug waste strategy.
Register now to CRISP - San Francisco, meet with our N-SIDE experts, and join our presentation!
Learn more about forecasting and risk-based optimization
Article
Forecasting and optimization in clinical trials
Learn about the latest advances in clinical trial forecasting and optimization. Understand how technology can help you overcome challenges you face in your clinical trial supply management.
Read Now
Webinar
Understanding the benefits of risk-based optimization on clinical trial supply planning
During this webinar, you will learn how to identify the differences between risk-based optimization and forecasting for clinical supply chain and manufacturing planning and much more!
Watch the replay
White paper
Understanding the differences between Simplicity and Reliability in Clinical Supply Forecasting
Forecasting tools don’t include several important factors, which can lead to less reliable results. Inaccurate forecasts threaten supply continuity, can lead to large amounts of drug waste and, in some cases, be risks to patient health.
Download it nowDo you want to know more?
